Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Ceramide Biosynthesis: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
The enzymatic synthesis of ceramide, a sphingolipid signaling molecule, via three pathways: de novo synthesis from serine and palmitoyl-CoA (SPTLC1/2, CERS enzymes), sphingomyelin hydrolysis by sphingomyelinases (SMPD1-5), and the salvage pathway. Ceramide acts as a pro-apoptotic second messenger and its dysregulation is implicated in neurodegeneration, insulin resistance, and cancer.
Ontology: GO:0046513 · MESH:D054928
No AI portrait yet
| Name | ceramide_biosynthesis |
| Key Genes/Proteins | SMPD1 |
| Related Diseases | lipid_raft_dysfunction |
| Target | Relation | Type | Str |
|---|---|---|---|
| lipid_raft_dysfunction | causes | phenotype | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| SMPD1 | modifies | gene | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 11 hypotheses Top: 0.950
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning Ceramide Biosynthesis in their description or question text
No additional research found